Home
 /
Papers
 /
Neuroscience
 /
A molecular and spinal circuit basis for the functional segregation of itch and pain
Preprint
Open access
V1
Top 1% · Validated by QED

A molecular and spinal circuit basis for the functional segregation of itch and pain

Myung-chul Noh, Kelly A. Corrigan, Sean-Paul G. Williams +15 more
August 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.07.31.667966
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Neuroscience this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

Hidden within a population deemed itch-exclusive, this study uncovers two functionally opposite neuron subtypes—one encoding itch, one encoding allodynia—overturning decades of spinal coding dogma and enabling modality-specific pain reversal in wild-type animals.

QED claims analysis

Summary

Transcriptomically distinct subtypes of Grpr+ dorsal horn neurons, distinguished by Tac1 expression and corresponding to species-conserved Exc-SKOR2 and Exc-LMO3 populations, mediate functionally segregated sensory modalities with Grpr+Tac1- neurons necessary for chemical itch and Grpr+Tac1+ neurons necessary for mechanical allodynia across diverse injury types, a functional segregation that can be therapeutically exploited through computationally designed genomic enhancers for modality-specific intervention.

See full analysis
Main Claim 1 –

Polyneuropathic mechanical allodynia engages distinct spinal circuits

Main Claim 2 –

Grpr+ neurons are required for mechanical allodynia across injuries

Supporting evidence

  • Polyneuropathic allodynia increases cFos in Grpr+ neurons
Main Claim 3 –

Tac1 separates Grpr+ subtypes Exc-SKOR2 and Exc-LMO3

Supporting evidence

  • Chemical itch activates Grpr+Tac1-; mechanical stimuli activate both
Main Claim 4 –

Grpr+Tac1- mediates itch; Grpr+Tac1+ mediates mechanical allodynia

Supporting evidence

  • iPV gates allodynia via Grpr+Tac1+; iPDYN gates both
  • TRAP2 labels bombesin-responsive Grpr+Tac1- itch neurons

Abstract

Recent advances reveal an extensive cellular diversity within the dorsal horn. How this complexity processes distinct sensations, like itch and pain, remains a fundamental question. We discovered hidden within a population of neurons expressing the gastrin-releasing peptide receptor (Grpr+), thought to be itch-specific, are highly homologous yet functionally distinct subtypes distinguished by expression of Tachykinin-1 (Tac1). While the Tac1- subtype mediates itch, the Tac1+ subtype mediates mechanical allodynia across diverse pain states. Inhibitory populations and differential sensitivities to GRP serve as key modulators of the Grpr+ neuron subtypes, shaping modality specific output. Leveraging computationally designed genomic enhancers to silence the Tac1- population reverses itch while silencing the Tac1+ subtype reverses mechanical allodynia broadly. The work demonstrates the nuance of differential sensory modality coding within the dorsal horn and the power of genomic enhancer-based strategies for modality-specific targeting.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?